期刊文献+

血浆脑利钠肽与房颤病人复律和复发的临床研究 被引量:1

Plasma Brain Natriuretic Peptide in Patients with Paroxysmal Atrial Fibrillation
下载PDF
导出
摘要 目的研究阵发性或持续性房颤(Af)病人转复窦性心律时,血浆脑利钠肽(BNP)水平及其临床意义。方法选取62例心功能(1-3)级病人,采用放免法测定房颤及窦性心律时病人血浆中BNP的浓度,观察两组BNP水平、房颤发作次数。结果病人房颤发生时BNP浓度为(88.36±22.32)pg/mL,比复律后窦性心律时(57.48±20.32)pg/mL明显增高(P〈0.05),高BNP水平病人组房颤发生次数较低BNP水平病人多。多因素分析显示血浆BNP水平与Af持续时间是转律后窦性心律维持的独立影响因子。结论血BNP浓度增高是发生心房颤动的预告因子,高水平的BNP更容易复发房颤,血浆BNP水平低或Af持续时间短者转律后窦性心律较易维持。 Objective To investigate the plasma concentration and clinical significance of brain natriuretic peptide (BNP) in the patients with paroxysmal atrial fibrillation. Methods Sixty - two patients with paroxysmal atrial fibrillation and cardiac function of grade 1 - 3 were enrolled, The plasma concentration during the episode of atrial fibrillation and sinus rhythm were measured by RIA technique. The difference between two groups was compared. The follow- up period was 12 months. The BNP level and the episode of atrial fibrillation were analyzed by logistic regression analysis. Results The plasma concentration of BNP in the episode of atrial fibrillation was higher than that during sinus rhythm. The level of BNP in the episode of atrial fibrillation and AF time were independent factors. Conclusion The plasma BNP was the predictor of the incurrence of atrial fibrillation. The patients with higher level of BNP were more predispose to the recurrence of atrial fibrillation. The sinus rhythm could be controlled easily in the patients with lower level of BNP and AF shorter persistent time.
出处 《中西医结合心脑血管病杂志》 2007年第4期320-321,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 血浆脑利钠肽 心房颤动 窦性心律 brain natriuretic peptide paroxysmal atrial fibrillation
  • 相关文献

参考文献10

  • 1Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain[J ].Nature,1988,332:78-81.
  • 2Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J].J Card Fail,2000,6:92-96.
  • 3Horie H,Tsutamoto T,Minai K,et al.Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome[J ].Jpn Circ J,2000,64:965-970.
  • 4Mabuchi N,Tsutamoto T,Maeda K,et al.Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patient with mild congestive heart failure[J].Jpn Circ J,2000,64:765 -771.
  • 5Vinch CS,Rashkin J,Logsetty G,et al.Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm[J].Cardiology,2004,102:188-193.
  • 6Wozakowska-Kaplon B.Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrilla[J].Am J Cardiol,2004,93:1555 1558.
  • 7Albage A,Kenneback G,Vanderlinden J,et al.Improved neurohormonalmarkers of ventricular function after restoring sinus rhythm by the maze procedure[J].Ann Thorac Surg,2003,75(3):790-795.
  • 8Akahashi Y,Yoshito I,Takahashi A,et al.AV nodal ablation and pacemaker implantation improves hemodynamic function in atrial fibrillation[J].Pacing Clin Electrophysiol,2003,26(5):1212-1217.
  • 9Jourdain P,Bellorini M,Funck F,et al.Shortterm effects of sinus rhythm restoration in patients with lone atrial fibrillation:A hormonal study[J].Eur J Heart Fail,2002,4(3):263-267.
  • 10Shimizu H,Murakami Y,Inoue S,et al.High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation[ J ].Stroke,2002,33 (4):1005-1010.

同被引文献9

  • 1Wijffels MC,Kirchhof CJ,Dorland R,et al.Atrial fibrillation begetsatrial fibrillation.A study in awake chronically in strumented goats[J].Circulation,1995,92(7):1954-1968.
  • 2de Denus S,Pharand C,Williamson DR.William son Brain natri-uretic peptide in the management of heart failure:the versatile neu-rohormone[J].Chest,2004,125(2):652-668.
  • 3Asselbergs FW,van den Berg MP,Bakker SJ,et al.N-terminal proB-type natriuretic peptide levels predict newly detected atrial fibril-lation in a population-based cohort[J].Neth Heart J,2008,16(3):73-78.
  • 4Struthers A,Lang C.The potential to improve primary prevention inthe future by using BNP/N-BNP as an indicator of silent'pancardi-ac'target organ damage[J].Eur Heart J,2007,28(14):1678-1682.
  • 5Bagnall AJ,Kelland NF,Gulliver-Sloan F,et al.Deletion of endo-thelial cell endothelin b receptors does not affect blood pressure orsensitivity to salt[J].Clin Sci,2000,98(1):65-70.
  • 6Conway DS,Pearce LA,Chin BS,et al.Prognostic Value of plasmavon willebrand factor and soluble P-selectin as indices of endotheli-al damage and platelet activation in 994 patients with nonvalvularatrial fibrillation[J].Circulation,2003,107(25):3141-3145.
  • 7Maas R,Schwedhelm E,Albsmeier J,et al.The pathophysiology oferectile dysfunction related to endothelial dysfunction and media-tors of vascular function[J].Vasc Med,2002,7(3):213-225.
  • 8Kumagai K,Nakashima H,Saku K,et al.The HMG-CoA reductaseinhibitor atorvastatin prevents atrial fibrillation by inhibiting in-flammation in a canine sterile pericarditis model[J].CardiovascRes,2004,62(1):105-111.
  • 9刘丽敏,刘兆奕.慢性房颤患者血清ANP和BNP水平及其临床意义分析[J].中国冶金工业医学杂志,2009,26(4):380-381. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部